Elliot Sigal insider trades: Spark Therapeutics (ONCE) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Elliot reports to the SEC
Open-market buys and sales
17 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 28, 2017 | ONCE | ↓ Sell | 29 | $72.43 | $2K | Direct | Apr 16, 2018 (139d) |
| Oct 12, 2017 | ONCE | ↑ Buy | 29 | $90.75 | $3K | Direct | Apr 16, 2018 (186d) |
| Feb 4, 2015 | ONCE | ↑ Buy | 5,000 | $23.00 | $115K | Direct | Feb 6, 2015 (2d) |
| Jun 3, 2013 | BMY | ↓ Sell | 83,647 | $48.18 | $4.0M | Direct | Jun 5, 2013 (2d) |
| May 30, 2013 | BMY | ↓ Sell | 143,521 | $47.23 | $6.8M | Direct | May 31, 2013 (1d) |
| Apr 30, 2013 | BMY | ↓ Sell | 458,427 | $39.68 | $18.2M | Direct | May 1, 2013 (1d) |
| Apr 30, 2013 | BMY | ↓ Sell | 19,232 | $39.95 | $768K | By C. Elliott Sigal 2012 Irrevocable Tru | May 1, 2013 (1d) |
| Apr 30, 2013 | BMY | ↓ Sell | 19,232 | $39.95 | $768K | By Ruth L. Sigal Irrevocable Trust | May 1, 2013 (1d) |
| Apr 30, 2013 | BMY | ↓ Sell | 9,616 | $39.95 | $384K | By Sigal Family Investments, LLC | May 1, 2013 (1d) |
| Feb 8, 2013 | BMY | ↓ Sell | 224,705 | $36.79 | $8.3M | Direct | Feb 11, 2013 (3d) |
| Dec 11, 2012 | BMY | ↓ Sell | 62,903 | $33.00 | $2.1M | By Ruth L. Sigal 2012 Irrevocable Trust | Dec 13, 2012 (2d) |
| Dec 11, 2012 | BMY | ↓ Sell | 62,903 | $33.00 | $2.1M | By C. Elliott Sigal 2012 Irrevocable Tru | Dec 13, 2012 (2d) |
| Dec 11, 2012 | BMY | ↓ Sell | 31,451 | $33.00 | $1.0M | By Sigal Family Investments, LLC | Dec 13, 2012 (2d) |
| Jan 3, 2012 | MJN | ↑ Buy | 47 | $56.39 | $3K | By BMS 401(k) Plan | Sep 14, 2012 (255d) |
| May 18, 2011 | BMY | ↓ Sell | 71,535 | $28.90 | $2.1M | Direct | May 18, 2011 (0d) |
| Mar 15, 2010 | BMY | ↓ Sell | 47,563 | $25.94 | $1.2M | Direct | Mar 17, 2010 (2d) |
| Apr 30, 2009 | BMY | ↑ Buy | 15,000 | $19.18 | $288K | Direct | Apr 30, 2009 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Elliot Sigal's insider trades
Elliot Sigal is a director at Spark Therapeutics (ONCE). Since Apr 30, 2009, Elliot has reported 4 open-market purchases worth $408K and 13 sales worth $47.7M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include shares withheld for taxes (30 filings), option exercises (23 filings), grants and awards (23 filings), other transactions (11 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ONCE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.